ArticleCOVID-19 among Rheumatoid Arthritis Patients on Immunosuppressive Therapy During the First Wave of the COVID-19 Pandemic: a Prospective Comparative Study
ArticleCOVID-19 among Rheumatoid Arthritis Patients on Immunosuppressive Therapy During the First Wave of the COVID-19 Pandemic: a Prospective Comparative Study
ArticleEFFECTIVENESS AND SAFETY OF INACTIVATED COVID-19 VACCINE IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING ANTI-TNF COMPARED TO HEALTHY EGYPTIAN POPULATION
ArticleEFFECTIVENESS AND SAFETY OF INACTIVATED COVID-19 VACCINE IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING ANTI-TNF COMPARED TO HEALTHY EGYPTIAN POPULATION
ArticleKNOWLEDGE ATTITUDE AND PRACTICE TOWARDS COVID-19 AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
ArticleKNOWLEDGE ATTITUDE AND PRACTICE TOWARDS COVID-19 AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
ArticleImmunogenicity and Adverse Events after Coronavirus Disease 2019 (COVID-19) Vaccination in Patients with Systemic Inflammatory Autoimmune Diseases
ArticleImmunogenicity and Adverse Events after Coronavirus Disease 2019 (COVID-19) Vaccination in Patients with Systemic Inflammatory Autoimmune Diseases
ArticleInterleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity
ArticleInterleukin 36α Serum Level in Egyptian Patients with Systemic Lupus Erythematosus and its relation to Disease Activity